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Hypermobile Ehlers-Danlos 
Syndrome during pregnancy, 
birth and beyond
T he Ehlers-Danlos Syndromes (EDS) are a group of multisystemic, inherited conditions that affect connective tissue (Malfait et al, 2017). The various subtypes of EDS can share symptoms such as joint 
hypermobility and hyperextensible and/or fragile skin 
(Bloom et al, 2017), yet many EDS subtypes also include 
clinical characteristics relating to pain, extreme fatigue, 
irritable bowel, sleep disturbance, depression, anxiety 
and other cardiovascular, gastrointestinal, orthopaedic, 
oromandibular, neurological, allergic/immunological, 
and psychological aspects of health (Tinkle et al, 2017). 
The prevalence of EDS was historically estimated to be 1 
in 5000 for all subtypes (Beighton et al, 1998), although 
other work suggests a prevalence of 0.75-2% (Hakim 
and Sahota, 2006). There has been no high-quality 
prevalence study carried out since EDS received a major 
reclassification in 2017 (Tinkle et al, 2017).
Despite these estimated prevalence rates, EDS is 
considered to remain largely underdiagnosed (Castori, 
2012; Gazit et al, 2016). This is concerning for those 
receiving maternity care, as it is also associated with 
a number of complications relating to pregnancy and 
birth. Such complications can include precipitate labour, 
preterm rupture of membranes, scoliosis (problems 
with anaesthesia), atonic uterus, bleeding, vaginal and/
or perineal tears during birth, wound dehiscence and 
tissue fragility (Lawrence, 2005; Castori et al, 2012). This 
presents a unique opportunity for midwives and other 
members of the multidisciplinary team to understand, 
raise awareness of and more effectively support 
undiagnosed pregnant women, and those suspected of 
having or diagnosed with EDS. 
Those diagnosed with EDS perceive a lack of 
awareness among health professionals and describe 
delays in access to appropriate healthcare services (Terry 
et al, 2015). If EDS remains poorly understood by the 
multidisciplinary team, this may significantly compromise 
maternity care (Ross and Grahame, 2011). Consequently, 
this paper draws from wider literature and a number of 
key contemporary reviews to present evidence-based 
care considerations for both the mother and the neonate 
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during the antenatal, intrapartum and postnatal periods. 
However, this field of research is at the early stages of 
building an evidence base and much more research into 
this area is needed.
Abstract
The Ehlers-Danlos Syndromes (EDS) are an underdiagnosed 
group of conditions with implications and risks associated with 
childbearing. Those with EDS suggest that health professionals lack 
of awareness in this area, and consequently describe delays in access 
to appropriate healthcare services. This article draws on the existing 
international evidence available to present evidence-based care 
considerations for childbearing women with hypermobile Ehlers-
Danlos Syndrome (hEDS) throughout the antenatal, intrapartum 
and postnatal periods. Care considerations are also offered in 
relation to the care of the newborn infant. The management 
of hEDS in childbearing women and babies can be complex. 
Findings point to the need for a multidisciplinary approach to 
formulating individualised care plans in partnership with women. In 
understanding the evidence in relation to this issue, midwives will be 
better able to practice evidence-based and woman-centred care.
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The International EDS Consortium recognises 13 
EDS subtypes. While the much rarer vascular EDS 
holds the most significant risks for childbearing women, 
including arterial dissection/rupture, uterine rupture 
and haemorrhage (Murray et al, 2014); this article will 
primarily focus on hypermobility EDS (hEDS), as it is 
the most common form of EDS (Volkov et al, 2007). 
hEDS is part of the most recent reclassification (Tinkle 
et al, 2017), but in previous classification systems it was 
known as either Ehlers–Danlos syndrome type III or 
Ehlers–Danlos syndrome hypermobility type (Malfait et 
al, 2017; Smith, 2017). The reclassification also introduced 
a new hypermobility-based diagnosis; hypermobility 
spectrum disorder (HSD). Treatment for HSD and for 
those with a historical diagnosis of joint hypermobility 
syndrome will be the same as for hEDS. While Chetty 
and Norton have recently provided guidance for 
obstetric care in women with genetic disorders (Chetty 
and Norton, 2017), to the authors’ knowledge, this is 
the first paper to draw on existing evidence to explore 
midwifery care considerations for this unique subgroup 
of childbearing women.
Antenatal care considerations
Those with a variety of EDS subtypes report significantly 
higher rates of infertility than the general population 
(Hurst et al, 2014). As such, families may wish to access 
genetic counselling services, where individual hereditary 
factors can be explored more thoroughly. Some women 
may take medication; therefore, a pre-conceptual review 
would be advisable, as prescribed medications may need 
to be stopped or changed.
As one of the key features of EDS and its many 
subtypes is disordered collagen synthesis, it is considered 
reasonable to offer additional monitoring to women, 
beginning with earlier ultrasound scanning to confirm 
the pregnancy and to monitor cervical length as the 
pregnancy progresses (Hurst et al, 2014). It is also prudent 
to note that striae atrophicae (stretch marks) are common 
in those with hEDS and may well be present before a 
pregnancy occurs (Castori, 2012). This is also important 
when assessing maternal parity, where stretch marks may 
be taken as an indication of a previous pregnancy.
Following conception, increased levels of the relaxin 
hormone during pregnancy can exacerbate pre-existing 
joint elasticity and pain in those with hEDS (Atalla and 
Page 1988; Lind and Wallenburg, 2002; Volkov et al, 
2007). As such, these women are three times more likely 
to require referral for intervention due to pelvic girdle 
pain and instability than the general population (Lind 
and Wallenburg 2002; Tinkle, 2010). Consequently, the 
identification of excess joint mobility, joint dislocations, 
pelvic pain and/or instability may prompt an early referral 
to both physiotherapy and GP services. Appropriate 
maternal positioning should also be led by the mother 
throughout routine examinations, to minimise the risk 
of joint dislocations or excess pain.  
The elasticity of soft tissues means that there is an 
increased risk of profound varicose veins in the legs 
and the vulva during pregnancy (Tinkle, 2010), and 
compression hosiery and/or a referral to a vascular 
service may be advisable (Marsden et al, 2013). Likewise, 
while gastroesophageal reflux is a common complaint of 
pregnancy, those with hEDS can experience symptoms of 
this more frequently (Castori et al, 2010a), again thought 
to be due to the elasticity of soft tissues. Symptoms can 
be routinely managed with diet and lifestyle changes, 
such as avoiding fatty or spicy foods, remaining in an 
upright position, and taking antacids and/or alginates. It 
is worth trying to avoid opioids, as gastric symptoms can 
be exacerbated by their use (Levy 1993).
Women with hEDS often also experience postural 
orthostatic tachycardia syndrome (POTS) (Grigoriou 
et al, 2015), which could affect up to 78% of women 
(Gazit et al, 2003). POTS is defined by a rise in heart 
rate of >30 beats/min, or a heart rate of >120 beats/min 
reached within 10 min of head-up tilt when moving 
from supine to an upright position (Kanjwal et al, 2003). 
While this is significant to those with hEDS, it is also an 
important consideration for maternity services, as POTS 
predominantly occurs in women of childbearing age 
(Kanjwal et al, 2003). 
During pregnancy, cardiovascular changes such 
as peripheral venous pooling and inferior vena cava 
obstruction may exacerbate the symptoms of POTS, such 
as episodes of dizziness, nausea, palpitations, fatigue and 
fainting (Kanjwal et al, 2009). Allowing for and predicting 
such changes during routine antenatal examinations 
and intrapartum care could avoid misdiagnoses and/
or unnecessary intervention, as maternity care and 
postural positioning becomes tailored to the individual. 
Furthermore, it is useful to note that those with POTS 
frequently also experience episodes of hypotension, or of 
orthostatic intolerance (Jones and Ng, 2008). They may 
also experience dysautonomia, a term used to describe 
a malfunction of the wider autonomic nervous system 
(Tinkle, 2010). As such, adequate salt and fluid intake 
The mental wellbeing of those with all 
subtypes of EDS can also deteriorate further in 
conjunction with exacerbated fatigue and pain. 
For midwives, this means proactively making 
early and appropriate referrals to local services in 
partnership with the mother 
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is considered especially important in cases of POTS, 
particularly if vomiting occurs in early pregnancy. 
Nevertheless, some symptoms associated with POTS are 
reported to improve or remain stable during and after 
pregnancy (Kimpinski et al, 2010; Blitshteyn et al, 2012). 
In caring for the psychological wellbeing of women 
receiving maternity care at all stages, it is important 
to recognise that those with hEDS are more likely to 
experience depression and anxiety than the general 
population (Castori et al, 2010a; Baeza-Velasco et al, 
2011). The mental wellbeing of those with all subtypes 
of EDS can also deteriorate further in conjunction 
with exacerbated fatigue and pain (Voermans et al, 
2010; Rombaut et al, 2011). As such, it is important 
for the multidisciplinary team to manage pain and 
fatigue effectively in partnership with any mental 
health management strategies. For midwives, this means 
proactively making early and appropriate referrals to local 
services in partnership with the mother.
Intrapartum care considerations
While those with hEDS should not be discouraged 
from vaginal birth (Sundelin et al, 2017), there are other 
specific care considerations to be made for this unique 
subgroup of childbearing women. For example, due to 
the hypermobile nature of hEDS, it is practical to consider 
appropriate maternal positioning throughout labour and 
birth. In over-extending the hips via lithotomy or the 
McRoberts manoeuvre, excess pain and/or injury may 
be caused and unstable joints that dislocate easily may 
be loosened (Molloholli, 2011). These risks of injury 
may be increased by the use of either local or regional 
anaesthetic, as pain when joints dislocate may then be 
eliminated. Accurate record keeping and collaborative 
antenatal planning are therefore advisable to reduce the 
incidence of such complications. 
Due to the varied and changing molecular structure 
of collagen fibres, the skin and tissues of those with 
hEDS may have reduced strength and stiffness (Kålund 
et al, 1990). This puts those with hEDS at a higher risk 
of preterm premature rupture of membranes (PPROM), 
which may result in preterm birth (Levy, 2004; Bird, 
2007). This is because PPROM is specifically associated 
with a reduction in amnion collagen content, which is 
thought to relate to a disturbance in collagen metabolism 
(Hermanns-Lê and Piérard, 2016). Consequently, 
conditions such as hEDS may alter the chorionic fetal 
membranes to more readily induce PPROM. This 
particular risk factor may be documented to support 
informed clinical decision making. 
Such laxity in the soft tissues of those with hEDS 
has also been associated with an increased risk of fetal 
malpresentation, precipitous vaginal birth (<4 hours) 
with a frequency of 28-36% and uterine prolapse in 
childbearing (Roop and Brost, 1999; Golfier et al, 2001; 
Levy, 2004; Bird, 2007; Castori et al, 2010a; Ross and 
Grahame, 2011; Castori et al, 2012). Yet while known risk 
factors may aid clinical assessment in confirmed cases of 
hEDS, there is no clear advantage to vaginal vs caesarean 
birth or clear evidence to support the routine use of 
prophylactic interventions (Levy 2004, Knoepp et al, 
2013). Individual care plans should therefore be formed 
in partnership with the mother and multidisciplinary 
teams until further evidence becomes available.
Easy bruising and bleeding is common in all types of 
EDS (Paepe and Malfait, 2004) and can manifest with 
mucosal fragility (Coster et al, 2005). Moreover, once a 
certain load is applied to the skin of those with reduced 
stiffness and increased fragility, greater deformation and 
injury can occur (Kaalund et al, 1990). If a childbearing 
woman feels that this is a risk, it is therefore prudent to 
work with her to optimise birth positions and techniques 
that encourage skin collagen and the rectus abdominis 
muscles to adapt slowly to excess pressure and stretching 
during birth. As episiotomy in those with hEDS is 
associated with an increased risk of pelvic prolapse, birth 
via caesarean section may be preferred in cases where 
episiotomy would otherwise be clinically indicated 
(Wiesmann et al, 2014).
In cases where local anaesthetic is required, it is 
important to recognise that local analgesia may be less 
effective or require higher doses for those with hEDS 
(Arendt‐Nielsen et al, 1990; Hakim et al, 2005). However, 
spinal analgesia is generally considered to be safe and 
effective for those with hEDS (Wiesmann et al, 2014), 
in addition to subarachnoid blocks, which have also 
been recorded as a suitable option for those with POTS 
(Motiaa et al, 2016). In order to consider individual 
risk factors, access to an early anaesthetic review during 
pregnancy may be advisable. 
For those experiencing POTS, labour presents a 
number of problems. Pain and stress may worsen any 
episodes of tachycardia (Motiaa et al, 2016); yet epidural 
analgesia can worsen haemodynamic instability via 
peripheral vasodilatation and hypotension (McEvoy et 
al, 2007). Moreover, during the second stage of labour, 
those with POTS can respond abnormally to performing 
the Valsalva manoeuvre (specifically, ‘purple’ pushing, 
where breath is held and used to direct pushing) (Stewart 
et al, 2005). Here, during the early phases of a Valsalva 
manoeuvre, a decrease in blood pressure can be noted, 
followed by a larger overshoot of blood pressure and an 
increased heart rate in the late phases, revealing greater 
hemodynamic instability in those with POTS. In one 
case (McEvoy et al, 2007), to counteract this, low dose 
epidural, invasive blood pressure monitoring, and a 
forceps-assisted birth were used to successfully diminish 
the Valsalva manoeuvres made by the mother. Where 
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appropriate, midwives could also usefully optimise 
strategies that promote spontaneous pushing in favour 
of directed pushing.
In other serious cases of POTS, birth via caesarean 
section has been recommended (Glatter et al, 2005), 
although the majority of patients with POTS are 
seemingly able to birth vaginally (Kanjwal et al, 2009). 
In cases where excess joint pain associated with hEDS 
becomes intolerable, birth via caesarean section may again 
be indicated (Dutta et al, 2011); yet, in all cases, midwives 
could usefully promote effective pain management and 
the use of therapeutic birthing environments to promote 
reductions in stress. Where indicated, it is important to 
note that birth via caesarean section does not come 
without its individual risk factors for women with EDS 
in the postnatal period.
Postnatal care considerations
Major postpartum complications for those with hEDS 
and other subtypes of EDS can include abnormal scar 
formation after either caesarean section or episiotomy 
(46.1%); haemorrhage (19.4%); pelvic prolapses, which 
may be associated with episiotomy (15.3%); deep venous 
thrombosis (4.2%); complicated perineal wounds (8%) 
and coccyx dislocation (1.4%) (Lind and Wallenburg 
2002; Jones and Ng; 2008, Castori et al, 2012). While the 
majority of such complications would be managed in line 
with standard recommendations, there are some specialist 
considerations to be made for those with hEDS. For 
example, birth injuries and the effects of other obstetric 
procedures can be further aggravated by poor wound 
healing and a higher risk of suture dehiscence during the 
postnatal period (Hakim and Grahame, 2003; Hakim et 
al, 2005; Castori 2012). As such, the use of non-tension, 
non-dissolvable, deep double sutures, left in for at least 14 
days is advisable (Chetty and Norton, 2017). Additionally, 
since local anaesthesia can be less effective for those with 
hEDS (Arendt‐Nielsen et al, 1990; Hakim et al, 2005), 
it is prudent to assess pain on an individual basis before 
commencing any type of surgical repair. Midwives may 
need to wait longer for local anaesthetics to take effect 
in those with hEDS, and/or administer larger doses in 
line with protocols.
Stress urinary incontinence has been found in 40%–
70% of women with hEDS (Arunkalaivanan et al, 2009; 
Castori et al, 2010b). This is thought to be associated 
with weakened pelvic floor, cystocele, bladder distention 
and pelvic prolapse caused by connective tissue 
abnormalities (Castori et al, 2010a; Tinkle, 2010; Tinkle 
et al, 2017). Such stresses can only be exacerbated by 
the added physical endurances of pregnancy and birth. 
Physiotherapy-based interventions throughout the 
antenatal and postnatal periods may therefore be useful 
for preventing, living with, and treating stress urinary 
incontinence (Sangsawang, 2014); however, in other cases, 
a medical or surgical referral may be most appropriate. A 
healthy diet and lifestyle, mobility care considerations and 
pelvic floor exercises may help to improve or reduce the 
risk of maternal symptoms (Sangsawang, 2014; National 
Institute for Heath and Care Excellence (NICE), 2017).
Neonatal care considerations
Given that pregnancy and birth can be a dangerous time 
for those with hEDS, there can also be significant risks 
for the neonate, and therefore it would be prudent to 
prepare for resuscitation and respiratory support due 
to prematurity and/or hypotonia if the neonate is also 
predicted to inherit any type of EDS (Lawrence, 2005). 
Though the risk of premature birth has already been 
established here, it is interesting to note that this was 
found to be more related to hEDS in the infant (40%), 
and less prevalent for maternal hEDS (21%) (Lind and 
Wallenburg, 2002).
There are also further opportunities presented during 
the Newborn Infant Physical Examination (NIPE) for 
midwives to initiate further multidisciplinary input 
where hEDS is present in either parent. Firstly, there is 
an opportunity to compare the infant’s overall tone and 
appearance to expectations appropriate for gestational 
age, considering that joint hyperlaxity and dislocatabilty 
is a common feature of hEDS (Lawrence, 2005). 
Unsurprisingly, in one cohort of children diagnosed 
with joint hypermobility/EDS (now classified as hEDS 
and HSDs), 12% had ‘clicky’ hips at birth and 4% were 
found to possess an actual congenital dislocatable hip 
(Adib et al, 2005). This may be a significant consideration 
when interpreting the findings from both Barlow and 
Ortolani hip manoeuvres (Kishta et al, 2017). As such, 
where hEDS is suspected, those who identify ‘clicky hips’ 
could usefully record this as being clinically significant. 
It is also useful to examine the baby’s skin at this time, 
as some babies with EDS will have skin that feels soft, 
velvet-like or ‘doughy’ (Beighton et al, 1998). It is also 
useful to inspect the forehead, chin, elbows, or knees for 
hyper extensible skin on the palm side of the forearm 
and observe for skin that splits easily (Lawrence, 2005, 
Beighton et al, 1998). While findings may be significant 
for ongoing care, it is important to note that subcutaneous 
newborn fat may impair some early assessments.
Box 1. Sources of information
For further information, please visit:
Ehlers-Danlos Support UK 
https://www.ehlers-danlos.org/
Hypermobility Syndromes Association 
http://hypermobility.org/
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Babies suspected of having hEDS may require 
additional joint support during general care and 
clinical procedures (Lawrence, 2005). In promoting the 
safeguarding of children, it is also important to consider 
that easy bruising and dislocation may be mistaken for 
mistreatment (Bird, 2007). In such cases, the accurate 
documentation of any bodily markings identified, along 
with symptoms consistent with hEDS, is paramount.
The role of midwifery
Midwives work in partnership with women and families 
to promote and optimise the childbearing experiences 
and outcomes. EDS remains underdiagnosed (Castori 
2012; Gazit et al, 2016), and so midwives have a unique 
opportunity to identify any potential signs and symptoms 
of hEDS that may require specialised clinical attention. 
Since the role of the midwife emphasises woman-centred 
care, midwives also have an opportunity to recognise, 
acknowledge and respect the distinctive needs, ideas, 
thoughts, emotions and expectations of childbearing 
women (Borrelli, 2014), including those who present 
with EDS symptomologies.
While it is not within a midwife’s remit to necessarily 
diagnose hEDS, the midwife is obliged to accurately 
assess any person receiving their care, and to make 
referrals where indicated (Nursing and Midwifery 
Council (NMC), 2015). Those with hEDS receiving 
maternity care may or may not be in possession of a firm 
diagnosis, yet the midwife’s awareness of hEDS and its 
effect on pregnancy may not only instigate more timely 
and appropriate referrals, but also improve the quality of 
any professional advice given. 
Midwives are required to practise in line with the 
best available evidence (NMC, 2015); yet there are 
no uniform management guidelines for childbearing 
women with hEDS, and the evidence available in relation 
to prevalence is sometimes highly conflicting (Tinkle et 
al, 2017). For example, in contrast to the majority of 
evidence presented in this paper, some studies reported 
that the incidences of adverse outcomes in those with 
some subtypes of EDS were no different from those in 
the general obstetrical population (Castori et al, 2012; 
Khalil et al, 2013; Hermanns-Lê et al, 2014; Sundelin 
et al, 2017). This presents additional challenges to 
educating and making the best evidence-based decisions 
in partnership with women. Additionally, for some 
women with EDS, symptoms may worsen (especially 
gastrointestinal complaints, fatigue, and pain), while for 
others they may improve or remain unchanged (Castori 
et al, 2012; Tinkle et al, 2017). It is also important to 
note that although many women and babies may present 
with joint hypermobility, not all will have a molecularly 
proven syndromic condition or experience symptoms 
that negatively affect their lives (Castori et al, 2017).
Conclusion
The management of hEDS in childbearing women 
and babies is complex. Yet, as hEDS remains largely 
underdiagnosed (Castori, 2012; Gazit et al, 2016), there 
is opportunity for midwives, childbearing women and 
multidisciplinary teams to address this issue in pursuit 
of optimal and evidence-based maternity care. This 
article has drawn on the existing evidence to explore the 
midwifery care considerations for childbearing women 
with hEDS.
The evidence presented here demonstrates how the 
complications associated with hEDS and childbearing 
can be significant; therefore, in the absence of obstetric 
management guidelines for hEDS pregnancies,  maternity 
care plans should be made and agreed in partnership with 
women and their families on an individual basis. Working 
in partnership with members of the multidisciplinary 
team will also be crucial in ensuring that those with 
EDS achieve the most appropriate maternity care plans 
and symptom management. 
In light of a paucity of evidence in this area, further 
high-quality research is required to address gaps in 
existing knowledge, facilitate evidence-based practice 
and formulate robust hEDS guidelines for pregnancy, 
birth and beyond. Midwives have an important role in 
the multidisciplinary team approach to caring for women 
with hEDS by providing routine care, identifying and 
reducing risk, making swift referrals where appropriate, 
supporting individualised care and giving evidence-
informed education to colleagues, childbearing women 
and the wider public. BJM
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Key points
 ● Pregnancies associated with hypermobile Ehlers-Danlos Syndrome (hEDS) are 
considered to be complex, with increased maternal and neonatal risks
 ● Those with all types of EDS report a lack of awareness among health 
professionals and therefore delayed access to appropriate care
 ● The risks associated with hEDS in childbearing include higher rates of 
infertility, preterm labour, preterm rupture of membranes, problems with 
anaesthesia, atonic uterus, bleeding, tears during birth, wound dehiscence, 
skin hyperextensibility, poor healing, fetal malpresentation, bruising, 
cardiac anomalies, mental health issues, pelvic prolapse, cervical tissue 
abnormalities, unstable joints and tissue fragility
 ● Individualised approaches to maternity care planning should be devised in 
partnership with the woman and multidisciplinary teams
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